Company logo

BFLY - Butterfly Network, Inc.

NYSE -> Healthcare -> Medical Devices
Guilford, United States
Type: Equity

BFLY price evolution
BFLY
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Current assets
Cash
Short term investments
Net receivables $20.62 $16.11 $13.91 $13.42
Inventory $73.27 $74.17 $74.49 $73.02
Total current assets $199.49 $204.48 $213.27 $231.26
Long term investments
Property, plant & equipment $35.78 $37.94 $39.75 $41
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $265.27 $273.07 $284.29 $304.27
Current liabilities
Accounts payable $3.65 $4.51 $5.81 $5.09
Deferred revenue
Short long term debt
Total current liabilities $42.79 $40.78 $41.54 $44.27
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $83.44 $78.79 $80.28 $84.22
Shareholders' equity
Retained earnings -$784.03 -$767.11 -$751.4 -$729.64
Other shareholder equity
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Jan 2021
Current assets
Cash $0.16
Short term investments
Net receivables $13.42 $14.69 $11.94
Inventory $73.02 $59.97 $36.24
Total current assets $231.26 $357.14 $511.9 $0.32
Long term investments
Property, plant & equipment $41 $52.9 $38.79
Goodwill & intangible assets
Total noncurrent assets $414.33
Total investments
Total assets $304.27 $417.57 $571.97 $414.65
Current liabilities
Accounts payable $5.09 $7.21 $5.8 $2.79
Deferred revenue
Short long term debt
Total current liabilities $44.27 $51.33 $49.83 $2.8
Long term debt
Total noncurrent liabilities $406.85
Total debt
Total liabilities $84.22 $92.21 $124.27 $409.65
Shareholders' equity
Retained earnings -$729.64 -$595.94 -$427.21 -$132.2
Other shareholder equity
Total shareholder equity
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Revenue
Total revenue $20.56 $21.49 $17.66 $16.52
Cost of revenue
Gross Profit $12.23 $12.59 $10.28 -$12.54
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $29.48 $29.82 $32.9 $34.19
Operating income
Income from continuing operations
EBIT
Income tax expense $0.06 $0.02 $0
Interest expense $0.9 $0.98 $1.21 $1.74
Net income
Net income -$16.92 -$15.71 -$21.76 -$44.12
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Jan 2021
Revenue
Total revenue $65.9 $73.39 $62.56
Cost of revenue
Gross Profit $16.86 $39.46 $17.05
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $160.67 $232.48 $209.78 $3.77
Operating income -$3.77
Income from continuing operations
EBIT
Income tax expense $0.08 $0.04 $0.12 $0.04
Interest expense $7.45 $3.38 $163.02
Net income
Net income -$133.7 -$168.72 -$32.41 -$132.2
Income (for common shares)
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$2.25 -$1.84 -$1.14 $70.41
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $0.23
Effect of exchange rate
Change in cash and equivalents -$40.84 -$32.5 -$21.8 -$28.18
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Jan 2021
Net income -$132.2
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$1.17
Investing activities
Capital expenditures
Investments
Total cash flows from investing $70.41 -$93.78 -$9.87 -$413.98
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $0.23 $2.88 $565.69 $415.3
Effect of exchange rate
Change in cash and equivalents -$28.18 -$260.02 $366.63 $0.16
Fundamentals
Market cap $849.81M
Enterprise value N/A
Shares outstanding 212.98M
Revenue $76.22M
EBITDA N/A
EBIT N/A
Net Income -$98.51M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -8.63
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 11.15
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS -$0.46
ROA -34.97%
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 4.66
Quick ratio 2.95